<DOC>
	<DOCNO>NCT00310765</DOCNO>
	<brief_summary>The purpose study evaluate pregabalin demonstrate significant reduction abdominal pain adhesion .</brief_summary>
	<brief_title>Pregabalin Abdominal Pain From Adhesions</brief_title>
	<detailed_description>The study prospective , double-blinded randomize . The study run 12 week . During first 7 week 2 group study subject receive placebo study drug . During last 4 week study , subject offer study medication , pregabalin . The primary outcome measure pain relief document 2-point change Likert pain scale secondary pain measure sleep interruption .</detailed_description>
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Tissue Adhesions</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Must history prior surgery document adhesion laparoscopy open laparotomy within 5 year Must undergone evaluation exclude cause abdominal pain Abdominal pain must present great three month duration Patients pregnant breast feed Prior treatment gabapentin , pregabalin demonstrate sensitivity drug Patients immunocompromised Patients significant hepatic renal insufficiency , significant hematologic disorder History illicit alcohol drug abuse within one year Documented serious unstable medical psychological condition Malignancy within past 5 year situ squamous cell carcinoma skin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>abdominal pain</keyword>
	<keyword>surgical adhesion</keyword>
</DOC>